About
I am CEO/CMO, drug developer and physician scientist with over 20 years of clinical and research experience in neuroscience and immunology. I have a passion for translating scientific insights into innovative treatments for patients with unmet medical needs. I was CEO at Nine Square Therapeutics, a biotech company that applies cutting-edge computational and experimental methods to discover and develop novel small-molecule therapeutics for life-threatening neurodegenerative diseases. Prior to joining Nine Square Therapeutics, I was the Chief Medical Officer at Alector, a pioneer in immuno-neurology, where I led the clinical development of multiple molecules in frontotemporal dementia, Alzheimer's disease, ALS, and oncology. I also oversaw the clinical development of several drug candidates for Alzheimer's disease, PSP, ALS, and pain at Genentech, where I held a senior leadership role in the neurology department. In addition, I have extensive business consulting experience in the biophar…
Experience
Consulting C Suite Level Executive & Drug Developer
Present
Chief Executive Officer
Nine Square Therapeutics · South San Francisco, California, United States
Chief Medical Officer
Ta Head Neuro Early Clinical Development Gred
Genentech · San Francisco Bay Area
Associate Group Medical Director
Senior Medical Director
Genentech · San Francisco Bay Area
Medical Director
Genentech · South San Francisco
Associate Medical Director
Clinical Lead for Alzheimer Drug Clinical Diagnostics in Alzheimer and MS
Neurologist
University of Munich
Project Leader
Associate
Research Associate
Education
Ludwig-Maximilians-Universität München
Habilitation, Neurology
Universität für Weiterbildung Krems
MBA, Biotech/Pharma Managment
Ludwig-Maximilians-Universität München
PhD
Ludwig-Maximilians-Universität München
MD, Medical Doctor
Ludwig-Maximilians-Universität München
Karlsgymnasium
Find leads like Robert
Origami finds your ideal customers across 15+ data sources with a single prompt.
Try Origami Free